Cellular characteristics of sputum from patients with asthma and chronic bronchitis

Gibson, P G; Girgis-Gabardo, A; Morris, M M; Mattoli, S; Kay, J M; Dolovich, J; Denburg, J; Hargreave, F E
September 1989
Thorax;Sep1989, Vol. 44 Issue 9, p693
Academic Journal
No abstract available.


Related Articles

  • Visclair.  // Royal Society of Medicine: Medicines;2002, p565 

    This article provides information on Visclair, a proprietary, non-prescription preparation of the mucolytic and expectorant mecysteine hydrochloride from Sinclair. This drug can be used to reduce the viscosity of sputum and thus facilitate expectoration in patients with chronic asthma or...

  • mecysteine hydrochloride.  // Royal Society of Medicine: Medicines;2002, p348 

    This article presents information on mecysteine hydrochloride or methyl cysteine hydrochloride, a drug used to reduce the viscosity of sputum and so acts as an expectorants in patients with disorders of the upper respiratory tract (eg chronic asthma or bronchitis). Administration is oral.

  • Chronic bronchitis: is bacteriological examination of sputum necessary? Peterson, I.C.; Petrie, G.R.; Crompton, G.K. // British Medical Journal;8/19/1978, Vol. 2 Issue 6136, p537 

    Assesses the necessity of routine bacteriological examination of purulent sputum for the management of infective exacerbations of chronic bronchitis. Performance of chemotherapy to patients; Conversion of sputum from purulent to mucoid; Valuability of specimen examination.

  • Asthma from childhood at age 21: the patient and his disease. Martin, A.J.; Landau, L.I.; Phelan, P.D. // British Medical Journal (Clinical Research Edition);2/6/1982, Vol. 284 Issue 6313, p380 

    Examines the effects of asthma on the lifestyle of the patients with the disease from childhood to age 21. Level of awareness on asthma among the patients; Incidence of smoking among asthma groups; Factors contributing to chronic production of sputum.

  • carbocisteine.  // Royal Society of Medicine: Medicines;2002, p138 

    This article presents information on the mucolytic drug carbocisteine. This drug is used to reduce the viscosity of sputum and thus acts as an expectorant in patients with disorders of the upper respiratory tract, such as chronic asthma and bronchitis. Administration is oral. This drug can...

  • Mucodyne.  // Royal Society of Medicine: Medicines;2002, p378 

    The article presents information on the respiratory agent mucodyne developed by Rhône-Poulenc Rorer and Aventis Pharma. The drug can be used to reduce the viscosity of sputum to facilitate expectoration in patients with chronic asthma or bronchitis. The drug is available as capsules and a syrup.

  • Clinical study to evaluate the efficacy of a compound Unani herbal formulation Sharbate-Unsul Murakkab in Sual-e-Muzmin (chronic bronchitis). Zaidi, S. A. R.; Ahmad, M. A.; Aslam, K. M.; Rauf, A.; Mukherjee, A. K. // Australian Journal of Medical Herbalism;2010, Vol. 22 Issue 3, p89 

    The present clinical study was undertaken as a single blind placebo controlled study to determine the efficacy of the test drug in the treatment of chronic bronchitis as there is no curative treatment available for chronic bronchitis in modern medicine. Unani compound formulation i.e....

  • VALOR DEL ESTUDIO CELULAR DEL ESPUTO EN EL SEGUIMIENTO DE LAS ENFERMEDADES INFLAMATORIAS DE LA VÍA AÉREA. Mazzei, Juan Antonio; Rocher, Adriana E.; Palaoro, Luis // Medicina (Buenos Aires);Aug2012, Vol. 72 Issue 4, p332 

    Cellular analysis of sputum either spontaneous or by induced sputum technique, has become a widespread tool for the evaluation and guidance of treatment of inflammatory diseases of the airway, primarily asthma, COPD and eosinophilic bronchitis. Induced sputum method is a validated, standardized...

  • Role of PGE2 in Asthma and Nonasthmatic Eosinophilic Bronchitis. Sastre, Beatriz; del Pozo, Victoria // Mediators of Inflammation;2012, Vol. 2012, p1 

    Eosinophilic bronchitis is a common cause of chronic cough, which like asthma is characterized by sputum eosinophilia, but unlike asthma there is no variable airflow obstruction or airway hyperresponsiveness. Several studies suggest that prostaglandins may play an important role in orchestrating...

  • Strong link found between asthma and COPD.  // Patient Care;Sep2004, Vol. 38 Issue 9, p10 

    Discusses research on the association of asthma with chronic obstructive pulmonary disease (COPD). Risk of patients with active asthma for acquiring symptoms of chronic bronchitis; Physiologic effect of the two diseases; Cause of the decline in pulmonary function in patients with COPD and asthma.


Read the Article


Sign out of this library

Other Topics